NEW YORK, Jan. 13, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
IntroductionThis analysis examines the historical and forecast performance for Watson in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.
Features and benefits
* Gain insight into Watson's strategic outlook across the next 6 years* Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source
HighlightsStrategic insight into the prospects for Watson over the next six years. Picking out key strengths, weaknesses, opportunities and threats and evaluating the company's prescription pharmaceuticals outlook using a variety of cuts of the historical and forecast sales.
Your key questions answered* Benchmark Watson's performance against key rivals in the prescription pharmaceutical sector* Analyze how the acquisition of Arrow Pharmaceuticals has provided Watson with a much enhanced geographic footprint* Assess how Watson will compete in an increasingly competitive generics market with enhanced specialist players and an increased Big Pharma presence
To order this report:: Watson Pharmaceuticals Inc.: PharmaVitae Profile
Copyright©2010 PR Newswire.
All rights reserved